Product Information
BUSPIRONE HCL 7.5 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1108 per EA under NDC 00378114501. Its NADAC has been published 652 times since Nov 28, 2013.
FDA first approved this application on Mar 28, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378114501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076008FDA Approved
3/28/2001
TE Code
AB
On Market Since
7/31/2013
Price Statistics
The NADAC for BUSPIRONE HCL 7.5 MG TABLET has been published 652 times since Nov 28, 2013, and over the history we have for it it has declined 87.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1108 per EA |
|---|---|
| All-time high | $0.9467 (Aug 12, 2015) |
| All-time low | $0.0797 (Nov 20, 2024) |
| 52-week high | $0.1212 |
| 52-week low | $0.1108 |
| Median price | $0.3735 |
| Average price | $0.4148 |
| Largest weekly change | -42.2% (Nov 20, 2024) |
| Weeks tracked | 652 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
-4.5%
1Y
-6.8%
3Y
-25.1%
5Y
-52.8%
All
-87.8%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 7.5 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.1108 per EA (NDC 00378114501), effective May 20, 2026.
How has the price of BUSPIRONE HCL 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has declined 87.8%. It has been tracked across 652 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 7.5 MG TABLET?
Since Nov 28, 2013, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has ranged from a low of $0.0797 (Nov 20, 2024) to a high of $0.9467 (Aug 12, 2015), with a median of $0.3735 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 7.5 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUSPIRONE HCL 7.5 MG TABLET, is $0.1046 per EA — about 6% below BUSPIRONE HCL 7.5 MG TABLET.
Who manufactures BUSPIRONE HCL 7.5 MG TABLET?
BUSPIRONE HCL 7.5 MG TABLET (NDC 00378114501) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.